Compound ID | 283
Synonym(s): 3-hydroxypyridine-2-carbonyloxy-bis(3-chloro-4-methylphenyl)borane | Compound 2g
Class: Small molecule antibacterial agent
| Agent Type: | Synthetic; Small molecule; Indirect acting; Antivirulence; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Also shows anti-inflammatory effect/ pro-inflammatory cytokine production inhibitor |
| Target Pathogen: | Active against Staphylococcus epidermidis and Propionibacterium acnes |
| Description: | Development intended for atopic dermatitis and acne, and as a toothpaste additive |
| Institute where first reported: | Anacor Pharmaceuticals, US; Naeja Pharmaceutical, Inc., Canada |
| Year first mentioned: | 2005 |
| Highest development stage: | Phase 1 (NCT00762151) |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/11704019 |
| Guide to Pharmacology: | AN0128 |
| Citation: | https://www.sciencedirect.com/science/article/pii/S0960894X06010456?via%3Dihub |